GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Retained Earnings

Notable Labs (Notable Labs) Retained Earnings : $-82.31 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Notable Labs's retained earnings for the quarter that ended in Dec. 2023 was $-82.31 Mil.

Notable Labs's quarterly retained earnings declined from Dec. 2021 ($-56.64 Mil) to Dec. 2022 ($-71.04 Mil) and declined from Dec. 2022 ($-71.04 Mil) to Dec. 2023 ($-82.31 Mil).

Notable Labs's annual retained earnings declined from Dec. 2021 ($-56.64 Mil) to Dec. 2022 ($-71.04 Mil) and declined from Dec. 2022 ($-71.04 Mil) to Dec. 2023 ($-82.31 Mil).

Notable Labs Retained Earnings Historical Data

The historical data trend for Notable Labs's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Retained Earnings Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Retained Earnings
-56.64 -71.04 -82.31

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Retained Earnings -56.64 -71.04 -82.31

Notable Labs Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Notable Labs  (NAS:NTBL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Retained Earnings
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.